Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: Effects of insulin and rosiglitazone

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 12, 2002, Pages 5662-5667

  Motoshima, Hiroyuki ^a   Wu, Xiangdong ^a   Sinha, Madhur K ^b   Hardy, V Elise ^a   Rosato, Ernest L ^a   Barbot, Donna J ^a   Rosato, Francis E ^a   Goldstein, Barry J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Linco Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; DNA; INSULIN; ROSIGLITAZONE;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BODY MASS; DNA CONTENT; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN SENSITIVITY; METABOLISM; OBESITY; OMENTUM; PRIORITY JOURNAL; PROTEIN SECRETION; SUBCUTANEOUS FAT;

ADIPOCYTES; ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CELLS, CULTURED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; OMENTUM; PROTEINS; SUBCUTANEOUS TISSUE; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0036930844     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020635     Document Type: Article

References (41)

1. Kolaczynski JW, Goldstein BJ 2000 The influence of obesity on the development of non-insulin-dependent diabetes mellitus. In: Lockwood DH, Heffner TG, eds. Obesity: Pathology and Therapy. Handbook of Experimental Pharmacology, vol 149. New York: Springer-Verlag; 91-119
2. Eckel RH 2001 Perspectives on vascular biology and diabetes. J Invest Med 49:100-103
3. Despres JP 2001 Health consequences of visceral obesity. Ann Med 33:534-541
4. Zierath JR, Livingston JN, Thorne A, Bolinder J, Reynisdottir S, Lonnqvist F, Arner P 1998 Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes - Relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia 41:1343-1354
5. Boden G 2001 Pathogenesis of type 2 diabetes - Insulin resistance. Endocrinol Metab Clin North Am 30:801-815
6. Arner P 2001 Regional differences in protein production by human adipose tissue. Biochem Soc Trans 29:72-75
7. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF 1995 A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746-26749
8. Hu E, Liang P, Spiegelman BM 1996 Adipo-q is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697-10703
9. Berg AH, Combs TP, Scherer PE 2002 ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84-89
10. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83
11. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y 2000 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arter Thromb Vasc Biol 20:1595-1599
12. Statnick MA, Beavers LS, Conner LJ, Corominola H, Johnson D, Hammond CD, Rafaeloff-Phail R, Seng T, Suter TM, Sluka JP, Ravussin E, Gadski RA, Caro JF 2000 Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 1:81-88
13. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
14. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y 2001 Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50:1126-1133
15. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y 1999 Novel modulator for endothelial adhesion molecules: Adipocytederived plasma protein adiponectin. Circulation 100:2473-2476
16. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y 2000 Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102:1296-1301
17. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MRS, Yen FT, Bihain BE, Lodish HF 2001 Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98:2005-2010
18. Berg AH, Combs TP, Du XL, Brownlee M, Scherer PE 2001 The adipocytesecreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953
19. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946
20. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L 2001 Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin. Invest 108:1875-1881
21. Goldstein BJ 1999 Current views on the mechanism of action of thiazolidinedione insulin sensitizers. Diabetes Technol Ther 1:267-275
22. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y 2001 PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094-2099
23. Moore GB, Chapman H, Holder JC, Lister CA, Piercy V, Smith SA, Clapham JC 2001 Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice. Biochem Biophys Res Commun 286:735-741
24. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T 2001 Mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPAR γ) deficiency and PPAR γ agonist improve insulin resistance. J Biol Chem 276:41245-41254
25. Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, Tanen M, Berg AH, O'Rahilly S, Savage DB, Chatterjee K, Weiss S, Larson PJ, Gottesdiener KM, Gertz BJ, Charron MJ, Scherer PE, Moller DE 2002 Induction of adipocyte complement-related protein of 30 kilodaltons by PPARγ agonists: A potential mechanism of insulin sensitization. Endocrinology 143:998-1007
26. Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y, Brichard SM 2001 Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 288:1102-1107
27. McTernan PG, Harte AL, Anderson LA, Green A, Smith SA, Holder JC, Barnett AH, Eggo MC, Kumar S 2002 Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes 51:1493-1498
28. Zimmet P, Alberti KGMM, Shaw J 2001 Global and societal implications of the diabetes epidemic. Nature 414:782-787
29. Reaven GM, Laws A 1999 Insulin Resistance: The Metabolic Syndrome X. Totowa, NJ: Humana Press
30. Saltiel AR 2001 You are what you secrete. Nat Med 7:887-888
31. Wu XD, Hoffstedt J, Deeb W, Singh R, Sedkova N, Zilbering A, Zhu L, Park PK, Arner P, Goldstein BJ 2001 Depot-specific variation in protein-tyrosine phosphatase activities in human omental and subcutaneous adipose tissue: A potential contribution to differential insulin sensitivity. J Clin Endocrinol Metab 86:5973-5980
32. Moller DE 2000 Potential role of TNF-α in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 11:212-217
33. Shulman GI 2000 Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176
34. Takahashi M, Arita Y, Yamagata K, Matsukawa Y, Okutomi K, Horie M, Shimomura I, Hotta K, Kuriyama H, Kihara S, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y 2000 Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 24:861-868
35. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM 2001 Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86:3815-3819
36. Arner P 1998 Not all fat is alike. Lancet 351:1301-1302
37. Sewter CP, Blows F, Vidal-Puig A, O'Rahilly S 2002 Regional differences in the response of human pre-adipocytes to PPAR γand RXR α agonists. Diabetes 51:718-723
38. Digby JE, Crowley VEF, Sewter CP, Whitehead JP, Prins JB, O'Rahilly S 2000 Depot-related and thiazolidinedione-responsive expression of uncoupling protein 2 (UCP2) in human adipocytes. Int J Obes 24:585-592
39. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VK, O'Rahilly S 1997 Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100:3149-3153
40. Rosenfeld MG, Glass CK 2001 Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 276:36865-36868
41. Matsuzawa Y, Funahashi T, Nakamura T 1999 Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 892:146-154